Novel Therapies for Resistant FSGS (FONTII): Phase II Clinical Trial
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Debbie Gipson, MD
University of Michigan
Principal Investigator - Howard Trachtman, MD
NYU Langone Medical Center
Principal Investigator - Jennifer Gassman, PhD
The Cleveland Clinic
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
18 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alberta
Edmonton, Alberta, Canada
- University of Miami
Miami, Florida, United States
- Emory University
Atlanta, Georgia, United States
- University of Kansas
Kansas City, Kansas, United States
- Boston Children'S Hospital
Boston, Massachusetts, United States
- University of Michigan
Ann Arbor, Michigan, United States
- Mayo Clinic
Rochester, Minnesota, United States
- Children'S Mercy Hospital
Kansas City, Missouri, United States
- Cardinal Glennon Children'S Medical Center
St Louis, Missouri, United States
- Steven and Alexandra Cohen Children'S Medical Center of New York
New Hyde Park, New York, United States
- Columbia University Medical Center
New York, New York, United States
- Nyu Langone Medical Center
New York, New York, United States
- Carolinas Medical Center
Charlotte, North Carolina, United States
- Cincinnati Children'S Hospital Medical Center
Cincinnati, Ohio, United States
- Ohio State University
Columbus, Ohio, United States
- Doernbecher Children'S Hospital
Portland, Oregon, United States
- Medical University of South Carolina
Charleston, South Carolina, United States
- Texas Tech University
El Paso, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Dec 2008
- Primary completion
- 30 Jun 2013
- Completion
- 28 Feb 2014
- Last update posted
- 11 Jul 2016
- Registered enrollment
- 32
- Registry id
- NCT00814255
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.